Following authorization by the FDA of the IND.

When tested hand and hand in the TRAMP prostate cancer tumor mouse model , APC-100 gave 90 percent efficacy versus the marketed Standard of Care giving 55 percent efficacy. In addition to increasing time to tumor survival and progression, APC-100 also induced a substantial reduction in PSA production. Adamis believes these characteristics make APC-100 a first-in-class substance for the potential treatment of castrate-delicate and castrate-resistant prostate cancer. Dr. Jeremy P. Cetnar, M.D., Principal Investigator for the study, stated, Since this molecule was originally created at the University of Wisconsin, we have become excited to be working with Adamis mainly because we move the medication from the basic research bench in to the clinical levels of development.As JFK said famously, Those that make peaceful revolution difficult will make violent revolution inevitable. At the proper time, he was discussing Latin America. He most likely did not recognize that barely fifty years later, the United States of America would devolve into a third-world nation of corruption, tyranny, and sexual perversion operate rampant through the entire ranks of corrupt government. Additional.. 5 reasons your digestive system isn’t working properly It seems nearly everyone has digestive issues these days. Crohn’s, IBS, colitis, celiac, and dozens of other digestion disorders have made an industry out of sugar free, gluten free of charge, and dairy free items.